Skip to main content

Atrial Fibrillation Clinical Trials

Atrial Fibrillation Clinical Trials Now Enrolling!

Suffering from unrhythmic & fluttering heartbeats due to AFib?

Atrial Fibrillation Clinical Trials May Be An Option!

An estimated 33.5 million people suffer from Atrial Fibrillation (AFib), which leaves them at risk for one of its most dangerous complication—stroke. People with this condition are usually asymptomatic and AFib is usually casually detected during a routine medical check-up.

Currently, atrial fibrillation complications can be managed by taking anticoagulants. However, these medications come with their fair share of risks. Prime Revival Research Institute is conducting Atrial Fibrillation Clinical Trials investigating a potential study drug (an anticoagulant) that may be able to help.

To be eligible to participate in the Atrial Fibrillation Clinical Trials, participants must be:

  • Over the age of 18 years old
  • Diagnosed with Atrial Fibrillation for at least 12 months

*Additional criteria may apply.

The goal of phase 3, atrial fibrillation clinical trials is to investigate a novel potential atrial fibrillation treatment option that may be able to help reduce the risk of stroke for people with this condition.

*To participate, please fill out the form and someone from the study care coordination team will contact you. If you fit the eligibility criteria and would like to participate, please know that your participation is completely voluntary.

*No insurance is required to participate. Participants may receive compensation for their time and travel.

Please provide YOUR contact information only.

About the Atrial Fibrillation Clinical Trials

We are conducting a phase 3, Atrial Fibrillation Clinical Trial to investigate the safety and efficacy of an investigational anticoagulant drug that may be used to manage the symptoms of AFib and reduce the risk of strokes. The atrial fibrillation treatments currently available are known to cause bleeding. At Prime Revival Research Institute, we are currently investigating a potential atrial fibrillation treatment option that may reduce the risk of stroke and have a lower effect on the risk of bleeding.

To be able to participate in the Atrial Fibrillation Clinical Trials, participants have to fulfill the participation criteria which include:

  • Being 18 years or older
  • Having had a documented diagnosis of Atrial Fibrillation within the last 12 months

Throughout the duration of the Atrial Fibrillation Clinical Trial, participants will receive study-related care from qualified healthcare professionals. And to investigate whether the study drug is safe and effective, our medical team will conduct medical tests and examinations.

*Participation in the Atrial Fibrillation Clinical Trials is completely voluntary. If you are eligible for the clinical trial and decide to participate, you will be asked to sign an Informed Consent Form.
We encourage participants to ask as many questions as they would like to regarding the clinical trial and their health before participating in the Atrial Fibrillation Clinical Trials.
*Participation is free of cost and does not require insurance.

About Atrial Fibrillation (AFib)

Atrial Fibrillation (AFib) is one of the most common arrhythmias (irregular heartbeats), which affects about 33.5 million people worldwide. This condition is most commonly known to affect the elderly population, although, it is known to affect 1% of the population under the age of 60 years. AFib is usually in its initial stages, asymptomatic, however, it can be detected through medical check-ups. Some of its most common symptoms include:

  • Heart Palpitations (the feeling of heartbeats being speeded up or irregular)
  • Dizziness
  • Nausea
  • Weakness
  • Shortness of breath
  • Chest pain

AFib is not usually life-threatening, however, it could lead to serious complications such as heart failure and stroke. Doctors and scientists worldwide are conducting research on AFib, in search of potential new atrial fibrillation treatment options that are safer and more effective that the current treatment options.

RecruitingSTATUS AND CRITERIA

$ 99

Per Month
  • Age 18 years and older
  • Gender Male and Female
  • Condition Atrial Fibrillation (AFib)
  • Location Texas
Enroll Now

What to Expect?

If you decide to participate by filling out the form above, someone from the study team will give you a call to see if you are eligible to participate. The study doctors have a full list of the requirements and will check to see if you fulfill the eligibility criteria for the Atrial Fibrillation Clinical Trials. If you fit the bill, you will be asked to visit the study site for screening. The location of the study site will be within a 50-mile radius of your current residence. The study doctors will guide you in regard to the duration of the atrial fibrillation clinical trials and what your participation in this research study entails. We encourage you to ask as many questions as you would like. Once everything is explained to the participants in detail, you will be asked to sign an Informed Consent Form.

Throughout the duration of the study, your health will be closely monitored by experienced doctors and a research team. The study may last for approximately 33 months. During the study, participants may be subject to some tests including blood sample collections and physical examinations. The study team including the study doctor will discuss in detail all the tests that will be conducted.

*Participants will receive the study care and investigational study, atrial fibrillation treatment, free of cost. Insurance is not required to participate.

FAQs

1. What is the main cause of Atrial Fibrillation?

Atrial fibrillation is caused by irregular heart rhythms. The heart is divided into 4 chambers (the upper two chambers being the right and left atria and, the lower two chambers being the right and left ventricles). These chambers naturally contract in sync with each other to produce a healthy heartbeat.

However, in the case of AFib, the atria quiver (shake) instead of contracting, this does not allow for the proper flow of blood into the ventricles. Due to the improper contraction of the ventricles, the pulse is often times irregular and fast. This may lead to symptoms such as heart palpitations, low blood pressure, and weakness.

2. What happens to a person with Atrial Fibrillation?

A person with AFib may have brief episodes of irregular heartbeats. Initially, a person with AFib might not have any symptoms. As the condition develops, they may have symptoms such as heart palpitations, dizziness, chest pain, nausea, or shortness of breath. If atrial fibrillation is not detected earlier or if atrial fibrillation treatment is not administered, it may lead to serious complications such as heart failure and stroke.

3. Where are the Atrial Fibrillation Clinical Trials conducted (study location)?

Our Cardiology sites are located in Texas. If you decide to participate, you may be invited to the study site which may be within a 50-mile radius of your current area of residence.

4. How does Atrial Fibrillation cause stroke?

The pooling of blood in the atrial chambers can cause blood clots to form within the heart. Traveling through the blood, these clots can exit the heart and block blood vessels in different parts of the body including the brain, arms, and legs. If blocks a vessel in the brain, there is a strong possibility that a stroke may occur.